Shull J H, Javadpour N, Soares T, Demoss E V
J Surg Oncol. 1981;18(2):193-6. doi: 10.1002/jso.2930180214.
The ABO(H) cell surface antigens of 13 breast carcinomas and 17 benign breast lesions were tested with a specific red cell adherence assay (SRCA). All 13 breast carcinomas, including 2 lobular carcinomas in situ and 1 noninfiltrating ductal carcinoma, had lost their ABO(H) surface antigens. Fourteen of 17 benign breast lesions had retained their ABO(H) surface antigens. The benign lesions losing their antigens were 1 case each of atypical intraductal hyperplasia, sclerosing adenosis, and intraductal papilloma. SRCA may be a predictor of which benign breast lesions are in fact premalignant.
采用特异性红细胞黏附试验(SRCA)检测了13例乳腺癌和17例乳腺良性病变的ABO(H)细胞表面抗原。13例乳腺癌,包括2例原位小叶癌和1例非浸润性导管癌,均已丧失其ABO(H)表面抗原。17例乳腺良性病变中有14例保留了其ABO(H)表面抗原。丧失抗原的良性病变分别为非典型导管内增生、硬化性腺病和导管内乳头状瘤各1例。SRCA可能是一种预测哪些乳腺良性病变实际上是癌前病变的指标。